Posts

Table of ContentsView AllTable of ContentsMenopause OverviewHow Common is It?EthnicityAge & GenderCausesEarly DetectionFrequently Asked Questions Table of ContentsView All View All Table of Contents Menopause Overview How Common is It? Ethnicity Age & Gender Causes Early Detection Frequently Asked Questions Menopauseis a normal part of aging for people who menstruate.The average age of menopause in the United States is 51. This article will review basic facts about menopause—including how common it is, who gets it, and how likely it is to cause complications....

Key TakeawaysSide effects of menopause in the workplace cost $1.8 billion a year.While uncommon in the U.S., menopause accommodations in the workplace are on the up-and-up.Change is most realistic if people experiencing perimenopause are open about their needs in order to reduce stigma. Key Takeaways Side effects of menopause in the workplace cost $1.8 billion a year.While uncommon in the U.S., menopause accommodations in the workplace are on the up-and-up.Change is most realistic if people experiencing perimenopause are open about their needs in order to reduce stigma....

Table of ContentsView AllTable of ContentsSymptomsCausesDurationTreatmentCopingNext in Menopause GuideSymptoms of Menopause Table of ContentsView All View All Table of Contents Symptoms Causes Duration Treatment Coping Next in Menopause Guide Menopause is the natural process that marks the end ofmenstrual periodsand your reproductive years. In most cases, this happens roughly between the ages of 45 and 55. It is also possible to have premature menopause or induced menopause due to surgery or an injury to theovaries....

Table of ContentsView AllTable of ContentsCausesWhat to DoPreventionDuration of MigraineSecondary Effects Table of ContentsView All View All Table of Contents Causes What to Do Prevention Duration of Migraine Secondary Effects Menstrual migraines develop around a person’s menstrual period, typically manifesting a couple of days before or after the start of menstrual flow. These headaches are pulsating, typically one-sided, and associated withnausea, vomiting, and light/sound sensitivity. Sometimes, anaura(reversible neurological symptoms) precedes the headache....

Key Takeaways Nearly all U.S. adults over the age of 65 have some mental health coverage through Medicare. But a recent Commonwealth Fund survey shows that it’s not enough. Munira Gunja, MPH, senior researcher in the Commonwealth Fund’s International Program in Health Policy and Practice Innovations, and her colleagues compared mental health needs and treatment of older adults in the U.S. to those of 10 other nations. They found that of all 11 countries, older adults with Medicare in the U....

Key TakeawaysCrisis Text Line began offering free mental health help in Spanish in mid-October, including via WhatsApp.Historically, there’s been a lack of representation in the mental health field, which means very few professionals can provide care in Spanish.Offering Crisis Text Line services in Spanish can be one step toward dismantling entrenched inequities in care, and can help normalize seeking help. Key Takeaways Crisis Text Line began offering free mental health help in Spanish in mid-October, including via WhatsApp....

Key TakeawaysDue to the pandemic, mental health professionals in the U.S. are seeing an influx of clients and patients.Many therapists have adjusted to telehealth, and hope to continue its use after a return to normalcy.If you’re having trouble finding a therapist, ask about potential referrals. Key Takeaways Due to the pandemic, mental health professionals in the U.S. are seeing an influx of clients and patients.Many therapists have adjusted to telehealth, and hope to continue its use after a return to normalcy....

Key Takeaways The drug, called molnupiravir, is authorized to treat mild to moderate COVID-19 in adults with a positive SARS-CoV-2 test who are at high risk for progressing to severe illness and/or hospitalization. It is available via prescription only. According Patrizia Cavazzoni, MD, director of the FDA’s Center for Drug Evaluation and Research, “Molnupiravir is limited to situations where other FDA-authorized treatments for COVID-19 are inaccessible or are not clinically appropriate....

Key TakeawaysAn experimental medication may help speed up COVID-19 in patients with more mild cases of the virus.The medication, called molnupiravir, would be the first oral drug specifically designed to fight COVID-19.Experts say early trial results are promising and could help cut back on the time infected people remain positive for the virus. Key Takeaways An experimental medication may help speed up COVID-19 in patients with more mild cases of the virus....

Key Takeaways The study results, based on a trial with 775 patients, showed that 7.3% of COVID-19 patients who received Molnupiravir were hospitalized or died within 29 days, compared with 14.1% who received the placebo. There were no reported deaths among those who received the pill, while eight deaths were recorded in patients who received the placebo. All patients were required to have at least one risk factor for poor disease outcome, such as obesity, diabetes, and heart disease....

Key TakeawaysMerck has joined forces with Johnson & Johnson to distribute the COVID-19 vaccine.The collaboration will help Johnson & Johnson get more vaccines to a greater number of people in a shorter period of time.Doctors applaud the move, as it will help more people get vaccinated. Key Takeaways Merck has joined forces with Johnson & Johnson to distribute the COVID-19 vaccine.The collaboration will help Johnson & Johnson get more vaccines to a greater number of people in a shorter period of time....

Key Takeaways One of the last remaining COVID-19 antivirals may be spawning new variants. In a preprint study published in January, a team of British researchers surveyed a global database of more than 13 million COVID-19 genome sequences. They found the genetic footprint of molnupiravir-associated mutations in clusters of cases, indicating these mutants are transmissible. The research has not yet been peer-reviewed. “A major reason to consider these effects is to judge whether there is a risk to wider public health from any potentially increased rate of SARS-CoV-2 evolution,”Theo Sanderson, PhD, a researcher at the Francis Crick Institute in London and a lead author of the study, told Verywell in an email....

Key Takeaways On Friday, the Center for Disease Control and Prevention’sAdvisory Committee for Immunization Practices(ACIP) unanimously greenlit a new vaccine from Merck that protects against 21 strains ofStreptococcus pneumoniae(S. pneumoniae), bacteria that can cause invasive pneumococcal diseases and pneumococcalpneumonia. The move follows approval from the Food and Drug Administration earlier this month. The vaccine, called Capvaxive (PSV21), is now recommended for thefollowing groups: The committee also recommended that individuals 65 and older who completed their vaccien series with both Prevnar 13 and Pneumovax 23 ask their providers if a dose of Capvaxive would be appropriate for them....